Introduction
Ralypod is Astemax Biotech’s high-quality WHO-GMP certified tablet combining Cefpodoxime Proxetil Axetil 200 mg and Ofloxacin 200 mg, delivering broad-spectrum antibacterial action for mixed infections.
Key Ingredients
Cefpodoxime Proxetil Axetil, a third-generation cephalosporin, disrupts bacterial cell wall synthesis to eliminate Gram-positive and Gram-negative pathogens. Ofloxacin, a fluoroquinolone, inhibits DNA gyrase and topoisomerase IV, preventing bacterial DNA replication and repair for synergistic killing effect.
Health Benefits
This potent duo treats respiratory tract infections (pneumonia, sinusitis), urinary tract infections, skin/soft tissue infections, and gynecological infections effectively, achieving rapid symptom relief and high cure rates in polymicrobial cases common in India.
Recommended Dosage
Take 1 tablet twice daily with food for 5-14 days, depending on infection severity; complete full course to prevent resistance development.
Usage Precautions
Avoid in cephalosporin/quinolone allergy, tendon disorders, or children under 12; monitor for GI upset, photosensitivity, or tendon pain. Astemax’s GMP standards ensure consistent potency and purity
